TRT week 3 update: separating real results from wishful thinking

What did @bigpuncustoms actually say?

At week three of testosterone replacement therapy, this creator reported losing roughly 1.5 pounds per week, energy levels dramatically up, brain fog lifting, mood improved, joint pain reduced, and muscle definition slowly returning. He also flagged something genuinely worth noting: his sleep apnea events increased from about 2.5 per hour to 3 to 3.5 per hour since starting TRT. He acknowledged eating poorly, exercising inconsistently, and said he hasn't done follow-up bloodwork yet. He expressed concern about estrogen and hematocrit levels, using nipple sensitivity as his informal estrogen proxy. His overall framing was that he "felt like a shadow" of himself before starting, and now feels like he's coming back to life.

To his credit, he's not selling anything, he's documenting a personal experience, and he flagged real clinical concerns instead of just posting wins. That matters when evaluating how responsibly this content is framed.

Does the science back this up?

Some of it, yes. The energy, mood, and cognitive improvements he describes at week three are plausible but almost certainly not from testosterone's pharmacological action alone. That's where things get complicated.

Testosterone cypionate or enanthate, the most common injectable forms used in TRT, typically take 4 to 6 weeks to reach stable serum levels, according to pharmacokinetic data reviewed by Bhasin et al. (2010, New England Journal of Medicine). Meaningful changes in body composition, libido, and red blood cell production generally emerge at 6 to 12 weeks. The improvements he's describing at week three, while real to him, are likely a combination of placebo effect, expectation, lifestyle changes (he cut soda, he's still going to the gym), and possibly some early neurological response to rising androgen levels.

The brain fog and low mood he describes before starting are consistent with hypogonadism symptoms documented in clinical literature. Zitzmann (2009, Nature Reviews Urology) found that men with low testosterone report significantly higher rates of depressive symptoms and cognitive complaints that do improve with TRT, but typically over months, not weeks.

The joint pain reduction he mentions is less well-supported. Testosterone has modest anti-inflammatory properties, but attributing joint pain relief at three weeks specifically to TRT is a stretch without a control comparison.

What did they get wrong (or right)?

He got the sleep apnea concern right, and that's actually the most medically important thing in this video. TRT is a known risk factor for worsening obstructive sleep apnea. A 2014 randomized trial by Schwartz et al. in JAMA Internal Medicine found TRT significantly increased the apnea-hypopnea index in older men with obesity. The mechanism is real: testosterone can alter upper airway muscle tone and increase neck circumference, exactly what he's observing.

Where he went wrong, or at least imprecise, is using nipple sensitivity as a reliable estrogen monitor. It's not. Gynecomastia and estradiol elevation can occur without nipple tenderness, especially early in the process. Estradiol should be measured with a sensitive assay, not guessed by feel.

He also says the previous clinic told him he'd gain 10 pounds in the first two weeks, which he's correctly calling out as inaccurate. That kind of claim reflects poor patient counseling. Initial weight changes on TRT can include water retention, but 10 pounds in two weeks is not a standard expectation.

His weight loss of about 1.5 pounds per week while eating poorly and exercising inconsistently is interesting. It could reflect improved insulin sensitivity, which is a documented effect of testosterone normalization (Kapoor et al., 2006, European Journal of Endocrinology), though three weeks is very early to attribute this confidently.

What should you actually know?

If you're watching this video and thinking about TRT, here's what the research actually says, separate from one person's three-week experience.

• TRT is a legitimate medical treatment for hypogonadism, defined by consistently low testosterone levels plus symptoms. It is not a general wellness upgrade for men with normal levels.
• Bloodwork matters more than how you feel at week three. Hematocrit, estradiol, PSA, and lipid panels should be monitored at regular intervals. He's waiting two more weeks per his doctor's protocol, which is reasonable.
• Sleep apnea is a real and underreported risk. Men with existing sleep apnea should be closely monitored on TRT. Worsening AHI events, as he describes, should be reported to the prescribing physician immediately, not managed by alternating between using and skipping the CPAP.
• Mood and energy improvements that feel dramatic at week three should be tracked over months. Studies like Snyder et al. (2016, NEJM) found that mood and energy improvements from TRT in older hypogonadal men were real but modest, and took consistent treatment over time.
• He is being transparent about his limitations: he's not a doctor, he's documenting his experience, and he's flagging concerns. That's more than many TRT influencers do.

Bottom line

This video is more honest than most TRT content on TikTok. The creator isn't overselling results, he's acknowledging the sleep apnea worsening, and he's waiting on bloodwork before drawing conclusions. The early benefits he reports are plausible but likely not purely pharmacological at week three. The sleep apnea signal he's casually mentioning deserves far more attention than he gave it.